RCUS ARCUS BIOSCIENCES INC

Ownership history in Man Group plc  ·  14 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in ARCUS BIOSCIENCES INC (RCUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 75,486 -1,433 -1.9% 0.00% $1.0M $13.60
2025 Q2 REDUCED 76,919 -25,739 -25.1% 0.00% $626K $8.14
2025 Q1 ADDED 102,658 +90,080 +716.2% 0.00% $806K $7.85
2024 Q4 REDUCED 12,578 -23,362 -65.0% 0.00% $187K $14.89
2024 Q3 ADDED 35,940 +19,832 +123.1% 0.00% $550K $15.29
2023 Q4 REDUCED 16,108 -38,056 -70.3% 0.00% $308K $19.10
2023 Q1 ADDED 54,164 +65 +0.1% 0.00% $988K $18.24
2022 Q4 ADDED 54,099 +45,696 +543.8% 0.00% $1.1M $20.68
2022 Q1 REDUCED 8,403 -10,693 -56.0% 0.00% $265K $31.56
2021 Q4 REDUCED 19,096 -2,856 -13.0% 0.00% $773K $40.47
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RCUS price (monthly, adj. close)
← Back to Man Group plc Holdings